jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

June. 18, 2022

June. 18, 2022

jRCT1070220016

Prospective randomized trial for success rate of left bundle branch pacing comparing anatomical
to electrical guided lead placement

Prospective randomized trial for success rate of left bundle branch pacing comparing anatomical
to electrical guided lead placement

Tsurugi Takuo

Saiseikai Kumamoto Hospita

5-3-1 Chikami Minami-ku Kumamoto city Kumamoto

+81-96-351-8000

takuo-tsurugi@saiseikaikumamoto.jp

Tsurugi Takuo

Saiseikai Kumamoto Hospita

5-3-1 Chikami Minami-ku Kumamoto city Kumamoto

+81-96-351-8000

takuo-tsurugi@saiseikaikumamoto.jp

Pending

June. 18, 2022

30

Interventional

randomized controlled trial

single blind

active control

parallel assignment

treatment purpose

(1) Written informed consent has been obtained for participation in this research from the patients or his / her substitute.
(2) Preoperative diagnosis (atrioventricular block, sinus node syndrome, bradycardic atrial fibrillation) is indicated for pacemaker implantation in accordance with the current JHRS guideline.
(3) The age at the time of informed consent is 18 years or older.

(1) Cases suspected of being complicated by infectious disease.
(2) The researcher judged that it would be difficult to follow up after one year.
(3) A patient who was eligible for pacing at His bundle, the apex of the right ventricle or right ventricular septum.
(4) A case in which the operator determined that left bundle brunch area pacing (LBBAP) was not appropriate.
(5) A patient who directly selected LBBAP with either electrophysiological or anatomical method.

20age old over
No limit

Both

Bradycardia

The Methods for Lead Implantation in Achievement of Optimal Left Bundle Branch Area Pacing

The primary outcome is success rate of selective LBBAP, which defined Qr or rSR'in V1 and left ventricular activation time (LVAT) < 75ms in V5

Secondary outcome are procedure time, fluoroscopic time, the dose of contrast agent, pacing threshold and impedance.

President and Chief Executive Officer Koichi Nakao
Saiseikai Kumamoto Hospital Ethics Committee
5-3-1 Chikami Minami-ku Kumamoto city Kumamoto, Kumamoto

+81-96-351-8000

rks@saiseikaikumamoto.jp
Approval

May. 30, 2021

No

none